New Issue: NanoViricides details $5.1 million private placements of common stock

By Devika Patel

Knoxville, Tenn., Oct. 6 - NanoViricides, Inc. took in $3.22 million from a private placement of restricted common stock on Sept. 30, according to an 8-K filed Tuesday with the Securities and Exchange Commission. It raised $1.88 million in another offering, which was exclusively for its warrant holders, for a total of $5.1 million.

The company sold 2,675,000 common shares and warrants for 1,337,500 shares in the first offering. It sold 3,759,800 shares and warrants for 3,759,800 shares in the second offering.

The warrants are exercisable at $1.00 for three years.

NanoViricides is a West Haven, Conn., biopharmaceutical company.

Issuer:	NanoViricides, Inc.
Issue:	Restricted common stock
Amount:	$5,097,300
Warrant expiration:	Three years
Warrant strike price:	$1.00
Agent:	Roth Capital Partners, LLC
Settlement date:	Sept. 30
Stock symbol:	OTCBB: NNVC
Stock price:	$0.82 at close Sept. 30
Market capitalization:	$98.4 million
First deal
Amount:	$3,217,400
Shares:	2,675,000
Warrants:	For 1,337,500 shares
Second deal
Amount:	$1,879,900
Shares:	3,759,800
Warrants:	For 3,759,800 shares

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.